Tibet Pharmaceuticals appoints Hong Yu CEO
This article was originally published in Scrip
Executive Summary
Tibet Pharmaceuticals, a developer, manufacturer and marketer of traditional Tibetan medicine in China, has appointed Hong Yu CEO, replacing Taylor Guo who will remain a director of the company. Mr Yu was previously chairman of Tibet Pharmaceuticals.